"Designing Growth Strategies is in our DNA"

U.S. Liquid Biopsy Market Size, Share & Industry Analysis, By Product (Assay Kits & Consumables, and Instruments), By Application (Oncology, Non-Invasive Prenatal Testing (NIPT), and Others), By End User (Hospitals, Clinical Laboratories, and Others), and Country Forecast, 2024-2032

Last Updated: December 01, 2025 | Format: PDF | Report ID: FBI107914

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Cancer, 2023
    2. Key Industry Developments - Mergers, Partnerships, & Acquisitions
    3. Recent Product Launches, By Key Players
    4. Impact of COVID-19 on the Market
  5. U.S. Liquid Biopsy Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Product
      1. Assay Kits & Consumables
      2. Instruments
    2. Market Analysis, Insights and Forecast – By Application
      1. Non-invasive Prenatal Testing (NIPT)
      2. Oncology
      3. Others
    3. Market Analysis, Insights and Forecast – By End User
      1. Hospitals
      2. Clinical Laboratories
      3. Others
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2023)
    2. Company Profiles (Overview, Product, SWOT Analysis, Recent Developments, Strategies, financials (Based on Availability))
      1. Guardant Health
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      2. PERSONALIS, INC.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      3. FOUNDATION MEDICINE, INC.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      4. Natera, Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      5. Illumina, Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      6. F. Hoffmann-La Roche Ltd
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      7. Menarini Silicon Biosystems, Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      8. Thermo Fisher Scientific Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      9. QIAGEN
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      10. Bio-Rad Laboratories, Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Cancer, 2023
    2. Key Industry Developments - Mergers, Partnerships, & Acquisitions
    3. Recent Product Launches, By Key Players
    4. Impact of COVID-19 on the Market
  5. U.S. Liquid Biopsy Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Product
      1. Assay Kits & Consumables
      2. Instruments
    2. Market Analysis, Insights and Forecast – By Application
      1. Non-invasive Prenatal Testing (NIPT)
      2. Oncology
      3. Others
    3. Market Analysis, Insights and Forecast – By End User
      1. Hospitals
      2. Clinical Laboratories
      3. Others
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2023)
    2. Company Profiles (Overview, Product, SWOT Analysis, Recent Developments, Strategies, financials (Based on Availability))
      1. Guardant Health
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      2. PERSONALIS, INC.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      3. FOUNDATION MEDICINE, INC.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      4. Natera, Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      5. Illumina, Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      6. F. Hoffmann-La Roche Ltd
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      7. Menarini Silicon Biosystems, Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      8. Thermo Fisher Scientific Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      9. QIAGEN
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      10. Bio-Rad Laboratories, Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
Read Less

Table 01: U.S. Liquid Biopsy Market Revenue (USD billion) Forecast, By Product, 2019-2032

Table 02: U.S. Liquid Biopsy Market Revenue (USD billion) Forecast, By Application, 2019-2032

Table 03: U.S. Liquid Biopsy Market Revenue (USD billion) Forecast, By End User, 2019-2032

Figure 01: U.S. Liquid Biopsy Market Revenue Breakdown (USD billion, %) by Product, 2024 & 2032

Figure 02: U.S. Liquid Biopsy Market Value Share (%), By Product, 2024 & 2032

Figure 03: U.S. Liquid Biopsy Market Value Share (%), By Application, 2024 & 2032

Figure 04: U.S. Liquid Biopsy Market Value Share (%), By End User, 2024 & 2032

Figure 05: U.S. Liquid Biopsy Market Share Analysis (%), By Company, 2023

U.S. Liquid Biopsy Market
  • 2019-2032
  • 2023
  • 2019-2022
  • 70
Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports